Stefanovic, an assistant professor in the department, has received a $143,000 two-year grant from the Scleroderma Foundation for his proposal to study cloning and characterization of RNA binding proteins which regulate expression of Type I collagen in scleroderma patients. Scleroderma is a chronic, often progressive, autoimmune disease in which a person’s immune system attacks his or her own body.